Here are relevant reports on : biotechnology-reagent-market
-
Protein Assays Market by Product (Reagent, Kit, Instruments), Type (Dye Binding, Test Strip), Application (Drug Discovery, Disease Diagnosis), Technology (Colorimetric, Fluorescence), End User (Pharmaceutical, Clinical Lab) - Global Forecasts to 2022
The protein assays market is projected to reach USD 2.41 Billion by 2022, at a CAGR of 11.1%. Some of the prominent players in the market are Thermo Fisher Scientific (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Merck KGaA (Germany), Cell Signaling Technology, Inc. (U.S.), General Electric Company (U.S.), and PerkinElmer Inc. (U.S.).
- Published: May 2017
- Price: $ 4950
- TOC Available:
-
North America Proteomics Market by Instrumentation (Mass Spectrometry, HPLC, Electrophoresis, Protein Microarray), Reagent (Immunoassay), Service (Purification, Bioinformatics), Software, Application (Clinical, Drug Discovery)- Forecast to 2030
The North America Proteomics market, valued at USD13.06 billion in 2024, stood at USD14.11 billion in 2025 and is projected to advance at a resilient CAGR of 12.7% from 2025 to 2030, culminating in a forecasted valuation of USD25.62 billion by the end of the period. The growing use of proteomics in precision oncology, cardiology, and other complex diseases, together with strong momentum in clinical trials, is driving demand for high-throughput, reliable platforms in hospitals and research centers.
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Metagenomic Sequencing Market by Product & Services (Reagent, Consumables, Instrument), Workflow (Sample Preparation, Sequencing), Technology (16S rRNA, Shotgun, Whole-genome), Application (Drug Discovery, Diagnostic, Industrial) - Global Forecast to 2028
The global metagenomic sequencing market, valued at US$1.8 billion in 2022, stood at US$2.0 billion in 2023 and is projected to advance at a resilient CAGR of 17.5% from 2023 to 2028, culminating in a forecasted valuation of US$4.5billion by the end of the period. NGS platforms have undergone continuous technological innovations over the last several years.
- Published: July 2023
- Price: $ 4950
- TOC Available:
-
Healthcare Data Monetization Market by Type (Direct, Indirect), Deployment (On-premise, Cloud), End User (Pharmaceutical & Biotechnology Companies, Healthcare Payers, Healthcare Providers, Medical Technology Companies) & Region- Global Forecast to 2030
The global healthcare data monetization market, valued at US$0.50 billion in 2024, stood at US$0.58 billion in 2025 and is projected to advance at a resilient CAGR of 14.9% from 2025 to 2030, culminating in a forecasted valuation of US$1.16 billion by the end of the period. The growth in this sector is driven by the increasing commercial value of real-time patient data, a growing emphasis on data-driven decision-making in life sciences, and the rise of data-as-a-service (DaaS) business models within healthcare.
- Published: June 2025
- Price: $ 4950
- TOC Available:
-
Viral Clearance Market by Application (Recombinant Proteins, Blood, Vaccines), End User (Pharmaceutical & Biotechnology Companies, CROs), Method (Viral Removal (Chromatography, Nanofiltration), Viral Inactivation (Low pH)) - Global Forecasts to 2023
The global viral clearance market is projected to reach USD 724.5 million by 2023, growing at a CAGR of 21.7%. The key players in the global viral clearance market are Wuxi Biologics (Cayman) (China), Merck KGaA (Germany), Charles River Laboratories International Inc. (US), and Texcell Inc. (France), Kedrion (Italy), Vironova Biosafety (Sweden), Clean Cells (France), BSL BIOSERVICE Scientific Laboratories Munich GmbH (Germany), and ViruSure GmbH (Austria).
- Published: September 2018
- Price: $ 4950
- TOC Available:
-
CRISPR Market by Product Type (Plasmids, Vectors, CAS9 Nuclease & GRNA, Delivery System), Application (Genetic Engineering, Cell Engineering) & End User (Biotechnology & Pharmaceutical Companies, Contract Research Organization) - Global Forecast to 2023
The global CRISPR market is expected to reach USD 4.16 billion by 2023 from USD 2.01 billion in 2018, growing at a CAGR of 15.7%. Increasing incidences and prevalence of genetic disorders, rising government funding on genomic research, increasing production of genetically modified crops and increasing demand for drug discovery are some of the major factors driving the growth of the global CRISPR market.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Healthcare RFID Market by Product (RFID tags, RFID readers, RFID printers), Application (tracking, monitoring), End User (Pharmaceutical and Biotechnology Companies, Hospitals) - Analysis and Global Forecasts to 2021
Radio-Frequency Identification (RFID) uses radio waves to read and capture information stored on a tag attached to an object. This tag can be read from several feet distance and does not need to be within direct line-of-sight of the reader. In healthcare industry, RFID technology can be used in supply chain applications, patient safety, and in quality assurance applications. RFID can be deployed in hospitals and clinics to improve patient flow, reduce medial errors, improve asset utilization rates, and mange inventories & implants, among others.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Sample Preparation Market by Product (Instruments (Workstations, Liquid Handling Systems), Consumables (Kits, Filters)), Application (Genomics, Proteomics), End Users (Pharmaceutical and Biotechnology, Food and Beverage) - Global Forecast to 2018
The global sample preparation market is expected to grow at a CAGR of 5.5%. Some of the prominent players in the sample preparation market includes Agilent Technologies, Inc. (U.S.), Danaher Corporation (U.S.), Illumina, Inc.(U.S.), QIAGEN N.V.(The Netherlands), PerkinElmer, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Norgen Biotek Corporation (Canada), Hamilton Company (U.S.), Tecan Group Ltd. (Switzerland), Merck (U.S.), Promega Corporation (U.S.), and Roche Applied Science(U.S).
- Published: June 2016
- Price: $ 4950
- TOC Available:
-
Drug Discovery Informatics Market by Function (Target Data, Sequencing Data Analysis, Docking), Solution (Software, Services), Application (Drug Development), End User (Pharmaceutical, Biotechnology, Contract Research Organizations) & Region - Global Forecast to 2025
The global drug discovery informatics market growth is primed to transition from $2.2 billion in 2020 to $3.5 billion by 2025, showcasing a strong CAGR of 9.3%. The market is primarily driven by increased R&D spending, especially in rare diseases, and the growing adoption of informatics in drug discovery.
- Published: April 2020
- Price: $ 4950
- TOC Available:
-
Trace Metal Analysis Market by Technology Instrument (Atomic Absorption Spectroscopy, X-Ray Fluorescence, ICP-MS), Service (FAAS, ICP-OES)), Application (Food & Beverage, Pharmaceutical & Biotechnology, Environmental Testing) - Global Forecast to 2024
The global trace metal analysis market is projected to reach USD 6.9 billion by 2024 from USD 4.4 billion in 2019, at a CAGR of 9.5%. The growth of this market is mainly driven by the stringent safety and quality regulations and new international cGMP & cGDP certification for pharmaceutical excipients, increasing spending on life science R&D, advancements in technologies, growing preference to outsource analytical requirements to third-party service providers, increasing demand from applied markets, rising opportunities in emerging countries, and the need to comply with revised USP guidelines. Prominent players in the trace metal analysis market are Thermo Fisher Scientific (US), Agilent Technologies (US), PerkinElmer, Inc. (US), Analytik Jena AG (Germany), Bruker Corporation (US), Hitachi Hi-Technologies Corporation (Japan), Rigaku Corporation (Japan), Shimadzu Corporation (Japan), Eurofins Scientific (Luxembourg), Intertek Group PLC (US), SGS S.A. (Switzerland), Bureau Veritas S.A. (France), TÜV SÜD (Germany), and LGC Ltd. (UK).
- Published: April 2019
- Price: $ 4950
- TOC Available:
Records 31 to 40 of 50
